synthesis media llc Press Releases

• Published on July 5, 2022 - 13:00 GMT

  

  Alessa Therapeutics Announces Dr. Pamela Munster appointed Chief Executive Officer

  Dr. Munster is a medical oncologist at UCSF and the founder of Alessa Therapeutics SAN CARLOS, CA, UNITED STATES, July 5, 2022 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug development company pioneering an innovative and …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on February 23, 2022 - 14:00 GMT

  

  Alessa Therapeutics Announces First Patient Enrollment in Biolen®+RT Study with National Cancer Institute

  Biolen+RT (NCT 04943536) is a Phase 1 clinical study conducted in collaboration with the Radiation Oncology Branch of the NCI SAN CARLOS, CA, UNITED STATES, February 23, 2022 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...
• Published on October 11, 2021 - 13:00 GMT

  

  Alessa Therapeutics Announces Research Collaboration with Janssen

  SAN CARLOS, CA, USA, October 11, 2021 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a clinical-stage drug development company developing implantable drug delivery systems focused on sustained delivery of drugs to solid organ tumors, announced that it …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on June 7, 2021 - 12:00 GMT

  

  Alessa Therapeutics Announces IND Clearance for a Study in Collaboration with the National Cancer Institute

  First patient enrollment anticipated in Q3 2021 for Phase 1 clinical study of Biolen in conjunction with radiation therapy in localized prostate cancer SAN CARLOS, CALIFORNIA, UNITED STATES, June 7, 2021 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on March 17, 2021 - 20:00 GMT

  

  Alessa Therapeutics Announces First Australian Patient Enrolled in Biolen-PC Study for New Therapy for Prostate Cancer

  Wollongong Private Hospital in NSW enrolls first patient in trial of new drug-delivery technology SAN CARLOS, CALIFORNIA, UNITED STATES, March 17, 2021 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a privately held drug development company developing …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on October 13, 2020 - 13:00 GMT

  

  Alessa Therapeutics Announces First Patient Enrolled in Biolen-PC Study for Localized Drug Delivery for Prostate Cancer

  SAN CARLOS, CALIFORNIA, US, October 13, 2020 /⁨EINPresswire.com⁩/ -- Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prostate disease, …

  Distribution channels: Healthcare & Pharmaceuticals Industry, International Organizations ...